======= LMO4 =======
== Gene Information ==
* **Official Symbol**: LMO4
* **Official Name**: LIM domain only 4
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8543|8543]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P61968|P61968]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LMO4&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LMO4|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603129|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Probable transcriptional factor. {ECO:0000250}.
|LIM|
|regulation of cell fate specification|
|spinal cord association neuron differentiation|
|ventral spinal cord interneuron differentiation|
|dorsal spinal cord development|
|enhancer sequence-specific DNA binding|
|regulation of cell fate commitment|
|spinal cord motor neuron differentiation|
|cell leading edge|
|thymus development|
|ventral spinal cord development|
|cell differentiation in spinal cord|
|ventricular septum development|
|neural tube closure|
|tube closure|
|primary neural tube formation|
|neural tube formation|
|spinal cord development|
|cardiac septum development|
|embryonic epithelial tube formation|
|cardiac ventricle development|
|negative regulation of protein complex assembly|
|epithelial tube formation|
|morphogenesis of embryonic epithelium|
|tube formation|
|neural tube development|
|cardiac chamber development|
|central nervous system neuron differentiation|
|transcription factor complex|
|epithelial tube morphogenesis|
|transcription factor binding|
|gland development|
|morphogenesis of an epithelium|
|regulation of protein complex assembly|
|transcription by RNA polymerase II|
|heart development|
|tissue morphogenesis|
|embryonic morphogenesis|
|positive regulation of kinase activity|
|hematopoietic or lymphoid organ development|
|chordate embryonic development|
|regulation of cell activation|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|immune system development|
|embryo development ending in birth or egg hatching|
|RNA biosynthetic process|
|tube morphogenesis|
|positive regulation of transferase activity|
|DNA-binding transcription factor activity|
|negative regulation of cellular component organization|
|tube development|
|regulation of cell migration|
|circulatory system development|
|regulation of kinase activity|
|anatomical structure formation involved in morphogenesis|
|regulation of cell motility|
|regulation of cellular component biogenesis|
|embryo development|
|regulation of transferase activity|
|central nervous system development|
|regulation of locomotion|
|regulation of cellular component movement|
|neuron differentiation|
|positive regulation of phosphorylation|
|nucleobase-containing compound biosynthetic process|
|epithelium development|
|positive regulation of phosphate metabolic process|
|positive regulation of phosphorus metabolic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|positive regulation of transcription by RNA polymerase II|
|organic cyclic compound biosynthetic process|
|positive regulation of catalytic activity|
|generation of neurons|
|positive regulation of transcription, DNA-templated|
|regulation of phosphorylation|
|neurogenesis|
|cellular nitrogen compound biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|positive regulation of RNA metabolic process|
|tissue development|
|macromolecule biosynthetic process|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|regulation of cell differentiation|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp306|Rapamycin 2μM R07 exp306]]|1.73|
|[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.31|
^Gene^Correlation^
|[[:human genes:g:golga6l1|GOLGA6L1]]|0.406|
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|1/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15624
* **Expression level (log2 read counts)**: 4.86
{{:chemogenomics:nalm6 dist.png?nolink |}}